JP2024519449A5 - - Google Patents
Info
- Publication number
- JP2024519449A5 JP2024519449A5 JP2023563934A JP2023563934A JP2024519449A5 JP 2024519449 A5 JP2024519449 A5 JP 2024519449A5 JP 2023563934 A JP2023563934 A JP 2023563934A JP 2023563934 A JP2023563934 A JP 2023563934A JP 2024519449 A5 JP2024519449 A5 JP 2024519449A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- use according
- subject
- day
- paclitaxel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163182519P | 2021-04-30 | 2021-04-30 | |
| US63/182,519 | 2021-04-30 | ||
| US202163193381P | 2021-05-26 | 2021-05-26 | |
| US63/193,381 | 2021-05-26 | ||
| US202263313882P | 2022-02-25 | 2022-02-25 | |
| US63/313,882 | 2022-02-25 | ||
| PCT/US2022/027142 WO2022232653A1 (en) | 2021-04-30 | 2022-04-29 | Combination of anti-galectin-9 antibodies and chemotherapeutics for use in cancer therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519449A JP2024519449A (ja) | 2024-05-14 |
| JP2024519449A5 true JP2024519449A5 (https=) | 2025-05-09 |
Family
ID=83847357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023563934A Pending JP2024519449A (ja) | 2021-04-30 | 2022-04-29 | がん治療における使用のための抗ガレクチン－９抗体と化学療法剤との併用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240182583A1 (https=) |
| EP (1) | EP4329808A4 (https=) |
| JP (1) | JP2024519449A (https=) |
| AU (1) | AU2022264597A1 (https=) |
| CA (1) | CA3217833A1 (https=) |
| IL (1) | IL308020A (https=) |
| WO (1) | WO2022232653A1 (https=) |
| ZA (1) | ZA202309774B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7581238B2 (ja) * | 2019-05-01 | 2024-11-12 | ニューヨーク・ユニバーシティ | 抗ガレクチン９抗体およびその使用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3080120C (en) * | 2017-10-27 | 2023-11-21 | New York University | Anti-galectin-9 antibodies and uses thereof |
| JP7581238B2 (ja) * | 2019-05-01 | 2024-11-12 | ニューヨーク・ユニバーシティ | 抗ガレクチン９抗体およびその使用 |
| US20220332832A1 (en) * | 2019-08-01 | 2022-10-20 | New York University | Combined cancer therapy of anti-galectin-9 antibodies and chemotherapeutics |
-
2022
- 2022-04-29 CA CA3217833A patent/CA3217833A1/en active Pending
- 2022-04-29 JP JP2023563934A patent/JP2024519449A/ja active Pending
- 2022-04-29 EP EP22796898.9A patent/EP4329808A4/en active Pending
- 2022-04-29 IL IL308020A patent/IL308020A/en unknown
- 2022-04-29 US US18/556,394 patent/US20240182583A1/en active Pending
- 2022-04-29 AU AU2022264597A patent/AU2022264597A1/en not_active Abandoned
- 2022-04-29 WO PCT/US2022/027142 patent/WO2022232653A1/en not_active Ceased
-
2023
- 2023-10-19 ZA ZA2023/09774A patent/ZA202309774B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543780A5 (https=) | ||
| ES2576289T3 (es) | Nanopartículas de paclitaxel y albúmina en combinación con bevacizumab contra el cáncer | |
| JP2022511394A5 (https=) | ||
| JP2022531408A5 (https=) | ||
| CN118267468A (zh) | 治疗肿瘤的联用药物组合物 | |
| EP4406538A1 (en) | Treatment of cancer patients having kras mutations | |
| JP2021510697A5 (https=) | ||
| TW202128224A (zh) | 抗ｐｄ－１抗體和組蛋白去乙醯化酶抑制劑的藥物組合及其用途、使用方法 | |
| Kobayashi et al. | Pharmacokinetic study of weekly administration dose of paclitaxel in patients with advanced or recurrent gastric cancer in Japan | |
| JP2024519449A5 (https=) | ||
| JP2021511344A5 (https=) | ||
| JP5605511B2 (ja) | 薬剤の併用による癌治療方法 | |
| JP6359198B1 (ja) | がん細胞の代謝の特異性に基づく新規抗悪性腫瘍剤 | |
| CA3134156C (en) | Chiauranib for treatment of small cell lung cancer | |
| CN115485029A (zh) | 用于肝癌的miv-818/乐伐替尼组合疗法 | |
| JP2024519450A5 (https=) | ||
| WO2025103379A1 (zh) | 抗b7h3抗体-药物偶联物治疗癌症的方法 | |
| CN121909048A (zh) | 抗b7h3抗体药物偶联物在制备治疗鼻咽癌和/或肺淋巴上皮瘤样癌的药物中的用途 | |
| WO2016098546A1 (ja) | 高齢又は末期の癌患者を治療又は寛解するための医薬組成物 | |
| Brandi et al. | Durable complete response of hepatocellular carcinoma after metronomic capecitabine | |
| JP2024502465A5 (https=) | ||
| HK40122430A (zh) | 抗b7h3抗体-药物偶联物治疗癌症的方法 | |
| JP2022531894A5 (https=) | ||
| Choi et al. | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | |
| US11911374B2 (en) | Methods and uses for treating cancer |